Maria Cristina Mingari Selected Research

Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)

11/2015	Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts.
5/2013	A novel human anti-syndecan-1 antibody inhibits vascular maturation and tumour growth in melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Cristina Mingari Research Topics

Disease

54	Neoplasms (Cancer) 01/2023 - 01/2002
18	Leukemia 01/2022 - 03/2005
14	Melanoma (Melanoma, Malignant) 01/2023 - 03/2009
5	Infections 01/2023 - 02/2007
4	Neoplasm Metastasis (Metastasis) 01/2019 - 09/2011
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2017 - 12/2002
3	Inflammation (Inflammations) 07/2022 - 08/2010
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 10/2017
2	Dry Eye Syndromes (Dry Eye Syndrome) 07/2022 - 10/2010
2	Ovarian Neoplasms (Ovarian Cancer) 02/2020 - 08/2011
2	Carcinoma (Carcinomatosis) 08/2019 - 05/2013
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018 - 11/2009
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2014 - 05/2014
2	Seroma 04/2014 - 06/2010
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2009 - 12/2002
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Ascites 02/2020
1	Ovarian Epithelial Carcinoma 02/2020
1	Pleural Effusion (Pleural Effusions) 01/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2014

Drug/Important Bio-Agent (IBA)

14	LigandsIBA 01/2020 - 07/2003
12	CytokinesIBA 01/2021 - 02/2008
5	Interleukin-15 (Interleukin 15)IBA 01/2023 - 09/2016
4	HLA-DR Antigens (HLA-DR)IBA 07/2022 - 02/2008
4	Proteins (Proteins, Gene)FDA Link 02/2020 - 06/2010
4	Interleukin-2 (IL2)IBA 08/2019 - 02/2013
4	Histocompatibility Antigens Class IIBA 10/2016 - 01/2002
3	Immune Checkpoint InhibitorsIBA 10/2022 - 01/2020
3	AntigensIBA 01/2021 - 07/2003
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 03/2009
3	Syndecan-1 (Syndecan 1)IBA 08/2019 - 05/2013
3	Protein Isoforms (Isoforms)IBA 08/2019 - 03/2009
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2019 - 01/2014
3	Monoclonal AntibodiesIBA 01/2019 - 05/2013
3	PerforinIBA 12/2015 - 01/2012
3	KIR ReceptorsIBA 01/2014 - 08/2002
2	Therapeutic UsesIBA 01/2022 - 01/2021
2	EnzymesIBA 01/2021 - 04/2016
2	Programmed Cell Death 1 ReceptorIBA 01/2021 - 01/2019
2	NivolumabIBA 01/2020 - 01/2019
2	Fibronectins (Fibronectin)IBA 08/2019 - 11/2015
2	L19-IL2 immunocytokineIBA 08/2019 - 11/2015
2	EpitopesIBA 12/2017 - 03/2009
2	HMGB1 Protein (HMG1)IBA 01/2016 - 12/2015
2	Natural Killer Cell ReceptorsIBA 12/2015 - 02/2007
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 11/2015 - 05/2013
2	NectinsIBA 03/2005 - 02/2005
1	NAD (NADH)IBA 01/2023
1	VemurafenibIBA 01/2023
1	Adenosine Monophosphate (AMP)IBA 01/2023
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	Broncho-VaxomIBA 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Glutathione (Reduced Glutathione)IBA 01/2023
1	Pyruvic Acid (Pyruvate)IBA 01/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023
1	Oxidoreductases (Dehydrogenase)IBA 01/2023
1	SuspensionsIBA 07/2022
1	Loteprednol Etabonate (Alrex)FDA Link 07/2022
1	Fluorescein (Funduscein)FDA LinkGeneric 07/2022
1	Histones (Histone)IBA 01/2021
1	GlucocorticoidsIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 03/2020
1	Carrier Proteins (Binding Protein)IBA 02/2020
1	Tyrosine (L-Tyrosine)FDA Link 02/2020
1	Interleukin-27 (Interleukin 27)IBA 02/2020
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020
1	AntibodiesIBA 01/2019
1	Vitamin D FDA LinkGeneric 01/2019
1	Phosphotransferases (Kinase)IBA 01/2018
1	matrigelIBA 01/2018
1	Chemokine ReceptorsIBA 01/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2018
1	pembrolizumabIBA 10/2017
1	Biomarkers (Surrogate Marker)IBA 10/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2016
1	mirdametinibIBA 09/2016
1	Interleukin-18 (Interleukin 18)IBA 09/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2016
1	Chemotactic FactorsIBA 12/2015
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 09/2015
1	Adenosine (Adenocard)FDA LinkGeneric 09/2015
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 06/2014
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 06/2014
1	Proto-Oncogene Proteins c-metIBA 06/2014
1	HLA-G Antigens (HLA G)IBA 05/2014

Therapy/Procedure

22	Therapeutics 01/2023 - 01/2011
17	Immunotherapy 01/2023 - 12/2009
10	Hematopoietic Stem Cell Transplantation 01/2021 - 03/2009
5	Transplantation 01/2019 - 03/2009
2	Stem Cell Transplantation 01/2017 - 11/2009
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 02/2006 - 12/2002
1	Investigational Therapies (Experimental Therapy) 03/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019
1	Immunomodulation 12/2015